Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Multiple Myeloma Publisher



Biglari M1 ; Shiraji ST1
Authors

Source: Comprehensive Hematology and Stem Cell Research: Volume 1-5 Published:2024


Abstract

Multiple myeloma is exemplified by the clonal proliferation of bone marrow plasma cells, with concomitant symptoms of anemia, renal impairment, bone lesions, and immunodeficiency. Emerging targeted therapies including immunomodulatory agents, proteasome inhibitors, and monoclonal antibodies have significantly improved disease prognosis. Treatment involves a personalized approach, encompassing induction treatment, stem cell transplantation, and maintenance regimens. Recent advancements like CAR-T cell treatment, in which redesigned patient's T cells are infused to eliminate certain myeloma antigens, show promise, especially in relapsed or refractory cases. Ongoing research continues to refine therapeutic strategies, aiming for deeper responses and prolonged remissions, ultimately enhancing patients' survival and quality of life. © 2024 Elsevier Inc. All rights are reserved.
Related Docs
View other Related Docs
1. Safety and Efficacy of Elotuzumab Combination Therapy for Patients With Multiple Myeloma: A Systematic Review and Meta-Analysis, Expert Review of Anticancer Therapy (2023)
2. Tumor Immunology, Clinical Immunology (2022)
3. Overall Survival of Multiple Myeloma in Autologous Stem Cell Transplantation: The Case of Patients in Dr. Shariati Hospital of Tehran, Human Gene (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Mohammad Vaezi (1)
Other Related Docs
4. A Systematic Review and Meta-Analysis on the Safety and Efficacy of Car T Cell Therapy Targeting Gprc5d in Patients With Multiple Myeloma: A New Insight in Cancer Immunotherapy, Anti-Cancer Agents in Medicinal Chemistry (2025)
5. Bridging the Gap Between Bone Marrow Transplantation and Car-T Cell Therapy in Hematological Cancers, Advances in Experimental Medicine and Biology (2025)
6. Diffusion-Weighted Imaging (Dwi) in Diagnosis, Staging, and Treatment Response Assessment of Multiple Myeloma: A Systematic Review and Meta-Analysis, Skeletal Radiology (2023)
7. Circrnas in Diagnosis, Prognosis, and Clinicopathological Features of Multiple Myeloma; a Systematic Review and Meta-Analysis, Cancer Cell International (2023)
8. Novel Car T Therapy Is a Ray of Hope in the Treatment of Seriously Ill Aml Patients, Stem Cell Research and Therapy (2021)
9. The Efficacy and Applicability of Chimeric Antigen Receptor (Car) T Cell-Based Regimens for Primary Bone Tumors: A Comprehensive Review of Current Evidence, Journal of Bone Oncology (2024)
10. The Molecular Landscape of T Cell Exhaustion in the Tumor Microenvironment and Reinvigoration Strategies, International Reviews of Immunology (2024)
11. Solid Tumors Challenges and New Insights of Car T Cell Engineering, Stem Cell Reviews and Reports (2019)
12. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
13. Car T Cell Therapy in Solid Tumors; With an Extensive Focus on Obstacles and Strategies to Overcome the Challenges, International Immunopharmacology (2021)
14. Integrative Analysis of Patient-Derived Tumoroids and Ex Vivo Organoid Modelling of Arid1a Loss in Bladder Cancer Reveals Therapeutic Molecular Targets, Cancer Letters (2025)
15. Anti-Ctla-4 Nanobody As a Promising Approach in Cancer Immunotherapy, Cell death & disease (2024)
16. Focusing on Exosomes to Overcome the Existing Bottlenecks of Car-T Cell Therapy, Inflammation and Regeneration (2024)
17. Post-Transplant Cyclophosphamide Versus Anti-Thymocyte Globulin As Graft- Versus-Host Disease Prophylaxis in Haploidentical Transplant, Haematologica (2017)
18. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
19. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells From Acute Myeloid Leukemia Patients, Iranian Journal of Allergy# Asthma and Immunology (2018)
20. Programmable and Multi-Targeted Cars: A New Breakthrough in Cancer Car-T Cell Therapy, Clinical and Translational Oncology (2021)